| Literature DB >> 27925053 |
Silvia Aguiar Rosa1, Ana Teresa Timóteo1, Marta Afonso Nogueira1, Adriana Belo2, Rui Cruz Ferreira1.
Abstract
OBJECTIVE: : To compare patients without previously diagnosed cardiovascular risk factors) and patients with one or more risk factors admitted with acute coronary syndrome.Entities:
Mesh:
Year: 2016 PMID: 27925053 PMCID: PMC5225915 DOI: 10.5935/0103-507X.20160065
Source DB: PubMed Journal: Rev Bras Ter Intensiva ISSN: 0103-507X
Figure 1Study flowchart.
Baseline clinical characteristics
| Characteristics | G0 | G1 - 2 | G ≥ 3 | p value |
|---|---|---|---|---|
| Male | 64.20 | 73.50 | 71.10 | 0.014 |
| Age (years) | 49 ± 8 | 62 ± 15 | 67 ± 12 | < 0.001 |
| Body mass index (kg/m2) | 26.7 ± 3.9 | 26.8 ± 4.2 | 27.8 ± 4.3 | < 0.001 |
| Hypertension | 0 | 40.6 | 88.2 | < 0.001 |
| Diabetes | 0 | 6.0 | 44.1 | < 0.001 |
| Dyslipidemia | 0 | 23.7 | 77.9 | < 0.001 |
| Smoker | 0 | 34.8 | 34.4 | < 0.001 |
| Family history of coronary artery disease | 0 | 4.5 | 11.0 | < 0.001 |
| Peripheral arterial disease | 0.7 | 1.8 | 3.9 | < 0.001 |
| Previous stroke | 1.3 | 4.2 | 9.2 | < 0.001 |
| Chronic kidney disease | 2.7 | 2.5 | 5.4 | < 0.001 |
| Neoplasm | 3.4 | 4.2 | 4.4 | 0.855 |
| Chronic obstructive pulmonary disease | 2.1 | 3.8 | 4.8 | 0.079 |
Chronic kidney disease: creatinine > 2.0mg/dL, hemodialysis or renal transplantation.
Chi-squared test;
ANOVA. Values are expressed as (%) and mean ± standard deviation.
Admission characteristics and hospital outcome
| Characteristics | G0 | G1 - 2 | G ≥ 3 | p value |
|---|---|---|---|---|
| Angina | 95.4 | 92.1 | 90.6 | 0.027 |
| Dyspneia | 0 | 2.5 | 3.7 | 0.004 |
| Syncope | 2.0 | 2.2 | 2.3 | 0.966 |
| STEMI | 57.6 | 54.3 | 47.3 | < 0.001 |
| Killip class I | 96.0 | 90.2 | 86.5 | < 0.001 |
| Heart rate (bpm) | 76 ± 18 | 76 ± 19 | 79 ± 19 | < 0.001 |
| Sinus rhythm | 95.4 | 93.2 | 91.5 | 0.028 |
| Systolic blood pressure (mmHg) | 132 ± 22 | 136 ± 28 | 141 ± 31 | < 0.001 |
| Hemoglobin on admission (g/dL) | 14 ± 1.6 | 14 ± 1.8 | 13.8 ± 1.9 | < 0.001 |
| Left ventricular ejection fraction | 56 ± 10 | 53 ± 12 | 53 ± 12 | 0.024 |
| Culprit artery - left anterior descending artery | 41.0 | 40.6 | 36.6 | 0.027* |
| Multivessel disease | 16.3 | 39.7 | 51.5 | < 0.001 |
| Percutaneous coronary intervention | 70.0 | 72.7 | 70.4 | 0.164 |
| Heart failure | 4.0 | 11.6 | 13.1 | 0.002 |
| Cardiogenic shock | 1.4 | 3.5 | 3.6 | 0.355 |
| Cardiac arrest | 6.6 | 3.0 | 2.7 | 0.021 |
| Mortality | 4.0 | 3.4 | 3.5 | 0.917 |
STEMI - ST segment elevation myocardial infarction;
Chi-squared test;
ANOVA. Values are expressed as (%) and mean ± standard deviation.
Statistical analysis to determine the predictors of cardiac arrest
| Variables | Multivariate analysis | Univariate analysis | ||||
|---|---|---|---|---|---|---|
| Coefficient | SE | p value | OR (95%CI) | p value | OR (95%CI) | |
| Risk factor 0 | 1.022 | 0.434 | 0.019 | 2.78 (1.19 - 6.51) | 0.007 | 2.57 (1.30 - 5.11) |
| Risk factors 1 - 2 | 0.126 | 0.200 | 0.529 | 1.13 (0.77 - 1.68) | 0.511 | 1.12 (0.81 - 1.54) |
| STEMI | 1.748 | 0.302 | < 0.001 | 5.74 (3.18 - 10.38) | < 0.001 | 6.32 (4.02 - 9.94) |
| Heart rate | 0.016 | 0.004 | < 0.001 | 1.02 (1.01 - 1.02) | < 0.001 | 1.01 (1.01 - 1.02) |
| SBP | -0.013 | 0.003 | < 0.001 | 0.99 (0.98 - 0.99) | < 0.001 | 0.98 (0.97 - 0.98) |
| KK > 1 | 1.266 | 0.229 | < 0.001 | 3.55 (2.27 - 5.56) | < 0.001 | 4.17 (2.97 - 5.87) |
| Nitratesin-hospital | -0.634 | 0.227 | 0.005 | 0.53 (0.34 - 0.83) | < 0.001 | 0.43 (0.30 - 0.61) |
SE - standard error; OR - odds ratio; 95%CI - 95% confidence intervals; STEMI - ST segment elevation myocardial infarction; SBP - systolic blood pressure; KK - Killip Kimball class.
Wald test;
comparing with 3 or more risk factors.
Statistical analysis to determine the predictors of hospital mortality
| Variables | Multivariate analysis | Univariate analysis | ||||
|---|---|---|---|---|---|---|
| Coefficient | SE | p value | OR (95%CI) | p value | OR (95%CI) | |
| Risk factor 0 | 0.862 | 1.056 | 0.414 | 2.37 (0.30; 18.76) | 0.764 | 1.14 (0.49 - 2.65) |
| Risk factors 1 - 2 | 0.028 | 0.204 | 0.892 | 1.03 (0.69; 1.53) | 0.818 | 0.97 (0.72 - 1.30) |
| Age | 0.068 | 0.009 | < 0.001 | 1.07 (1.05; 1.09) | < 0.001 | 1.10 (1.08 - 1.11) |
| STEMI | 1.011 | 0.237 | < 0.001 | 2.75 (1.73; 4.38) | < 0.001 | 3.11 (2.22 - 4.35) |
| SBP | -0.017 | 0.004 | < 0.001 | 0.98 (0.98; 0.99) | < 0.001 | 0.97 (0.96 - 0.97) |
| KK > 1 | 0.783 | 0.216 | < 0.001 | 2.19 (1.43; 3.34) | < 0.001 | 8.54 (6.32 - 11.53) |
| Beta-blockerin-hospital | -0.927 | 0.225 | < 0.001 | 0.40 (0.25; 0.61) | < 0.001 | 0.13 (0.10 - 0.18) |
| ACEI/ARBin-hospital | -0.922 | 0.240 | < 0.001 | 0.40 (0.25; 0.64) | < 0.001 | 0.12 (0.09 - 0.16) |
| No Cor/No PCI | 1.590 | 0.237 | < 0.001 | 4.90 (3.08; 7.80) | < 0.001 | 8.96 (6.52 - 12.29) |
| Cor/No PCI | 0.509 | 0.326 | 0.119 | 1.66 (0.88; 3.15) | 0.830 | 0.83 (0.51 - 1.36) |
| LVEF < 50% | 1.314 | 0.233 | < 0.001 | 3.72 (2.36; 5.87) | < 0.001 | 7.14 (4.75 - 10.71) |
SE - standard error. OR - odds ratio; 95%CI - 95% confidence intervals; STEMI - ST Segment elevation myocardial infarction; SBP - systolic blood pressure; KK - Killip-Kimball class; BB - beta-blocker; ACEI/ARB - angiotensin converting enzyme inhibitors/angiotensin II receptor blockers; Cor - coronary angiography; PCI - percutaneous coronary intervention, LVEF - left ventricular ejection fraction.
Wald test;
comparing with 3 or more risk factors;
comparing to coronary angiography/percutaneous coronary intervention.
Figure 2Kaplan Meier survival curves for the three study groups.
Statistical analysis to determine predictors of death at the one-year follow up
| Variables | Multivariate analysis | Univariate analysis | ||||
|---|---|---|---|---|---|---|
| Coefficient | SE | p value | OR (95%CI) | p valor | OR (95%CI) | |
| Risk factor 0 - 1 | 0.244 | 0.286 | 0.393 | 0.78 (0.45; 1.37) | 0.173 | 0.81 (0.59 - 1.10) |
| Age | 0.046 | 0.009 | < 0.001 | 1.05 (1.03; 1.06) | < 0.001 | 1.09 (1.08 - 1.10) |
| STEMI | 0.664 | 0.225 | 0.003 | 1.94 (1.25; 3.02) | < 0.001 | 2.33 (1.80 - 3.01) |
| ACEI/ARBdischarge | -0.598 | 0.227 | 0.008 | 0.55 (0.35; 0.86) | < 0.001 | 0.18 (0.13 - 0.25) |
| BBdischarge | -0.851 | 0.221 | < 0.001 | 0.43 (0.28; 0.66) | < 0.001 | 0.16 (0.11 - 0.22) |
| ASAdischarge | -1.460 | 0.229 | < 0.001 | 0.23 (0.15; 0.36) | < 0.001 | 0.08 (0.06 - 0.11) |
| No Cor/No PCI | 0.784 | 0.248 | 0.002 | 2.19 (1.35; 3.56) | < 0.001 | 6.95 (5.41 - 8.92) |
| Cor/No PCI | -0.251 | 0.323 | 0.439 | 0.78 (0.41; 1.47) | 0.838 | 0.96 (0.67 - 1.38) |
| LVEF<50% | 0.848 | 0.202 | < 0.001 | 2.34 (1.57; 3.47) | < 0.001 | 4.55 (3.44 - 6.02) |
SE - standard error; OR - odds ratio; 95%CI - 95% confidence intervals; RF- risk factors; STEMI - ST Segment elevation myocardial infarction; ACEI/ARB - angiotensin converting enzyme inhibitors/Angiotensin II receptor blockers; BB - beta-blocker; ASA - acetylsalicylic acid; Cor - coronary angiography; PCI - percutaneous coronary intervention, LVEF - left ventricular ejection fraction.
Wald test;
comparing with 3 or more risk factors;
comparing to coronary angiography/percutaneous coronary intervention.